CorMedix (CRMD) Shares Outstanding (2010 - 2025)

CorMedix (CRMD) has 16 years of Shares Outstanding (Entity) data on file, last reported at $67.9 million in Q2 2025.

• For the quarter ending Q2 2025, Shares Outstanding (Entity) rose 22.89% year-over-year to $67.9 million; the trailing twelve-month figure through Jun 2025 stood at $67.9 million (up 22.89% YoY), and the FY2024 full-year result was $64.4 million, up 17.24% from the prior year.
• Shares Outstanding (Entity) was little changed at $67.9 million in Q2 2025, from $67.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $67.9 million in Q2 2025 to a low of $38.0 million in Q1 2021.
• A 5-year average of $49.1 million and a median of $45.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) surged 45.77% in 2021 and gained 1.79% in 2022, its largest moves.
• Tracing CRMD's Shares Outstanding (Entity) over 5 years: stood at $38.1 million in 2021, then grew by 12.42% to $42.8 million in 2022, then advanced by 28.31% to $54.9 million in 2023, then gained by 17.24% to $64.4 million in 2024, then grew by 5.46% to $67.9 million in 2025.
• Business Quant data shows CRMD's Shares Outstanding (Entity) at $67.9 million in Q2 2025, $67.7 million in Q1 2025, and $64.4 million in Q4 2024.